The strategies below, drawn from clinical research and decades of subcutaneous injection best practice, reduce both the frequency and severity of reactions
Start at 2.5 mg, escalate every 4 weeks, monitor A1c and glucose response
Pharmacol Ther (2010) 125(1):16979
Contact the prescribing provider about persistent or severe symptoms
"Health Canada won't approve it as a drug, but it slips through as a compounded natural health product, where the federal safety check basically doesn't happen." Health Canada considers NHP compounding within a practitioner-patient relationship distinct from manufacturing and not subject to the same regulatory oversight
Y es casi tan fcil encontrar estudios a favor como en contra o, al menos, ponindola en entredicho